One death was complicated by the addition of TPO-RA therapy and a contraindication to anticoagulation due to a recent cerebral bleed, while the other had active pancreatitis, a genetic thrombophilia, and a severe anemia of unclear etiology with a contraindication to anticoagulation. The gene discussed is TPO; the disease is Rare hereditary thrombophilia.